Bank of America
TMBR

Bank of America’s Timber Pharmaceuticals, Inc. TMBR Stock Holding History

Bank of America’s Portfolio TMBR Stock Details TMBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed – – 9059
2021
Q4 		$0 Buy
+1
New +$28 ﹤0.01% 8919
2021
Q3 		– Hold
0
– – – 8570
2021
Q2 		– Hold
0
– – – 8307
2021
Q1 		– Sell
-1
Closed – – 7945
2020
Q4 		$0 Buy
+1
New +$50 ﹤0.01% 7485
2020
Q3 		– Sell
-19
Closed -$2K – 7310
2020
Q2 		$2K Buy
19
+1
+6% +$175 ﹤0.01% 6697
2020
Q1 		$3K Buy
+18
New +$4.59K ﹤0.01% 6601
2019
Q3 		– Hold
0
– – – 7620
2019
Q2 		– Hold
0
– – – 7521
2017
Q1 		– Hold
0
– – – 7337
2016
Q4 		– Hold
0
– – – 7433
2016
Q3 		– Hold
0
– – – 6857
2016
Q2 		– Hold
0
– – – 7484
2016
Q1 		– Hold
0
– – – 6893
2015
Q4 		– Hold
0
– – – 7535

Other funds holding TMBR

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of America's TMBR Position: Q1 2022 in Review

Bank of America sold out of Timber Pharmaceuticals, Inc. (TMBR) in Q1 2022, closing a stake of 1 share.

Bank of America first reported a position in TMBR in Q1 2020 and held it in 4 quarters. The position peaked at $3K in Q1 2020. 15 funds tracked by Wall St. Rank hold TMBR as of Q1 2022.

  • Bank of America reported no remaining Timber Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Bank of America sold 1 Timber Pharmaceuticals, Inc. share in Q1 2022.
  • Bank of America first reported a position in Timber Pharmaceuticals, Inc. in Q1 2020 and held it in 4 quarters.
  • Bank of America's Timber Pharmaceuticals, Inc. position peaked at $3K in Q1 2020.
  • 15 funds tracked by Wall St. Rank held Timber Pharmaceuticals, Inc. as of Q1 2022.

Based on Bank of America's 13F filing for Q1 2022, filed 16 May 2022.